div class=trans-pagebuttonPage 1button div class=trans-image a href=https:reader040fdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5page1jpg target=_blank amp-img class=trans-thumb alt=Page 1: crizotlnlb-atentionari · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut cursul pri src=https:reader040fdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 2button div class=trans-image a href=https:reader040fdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5page2jpg target=_blank amp-img class=trans-thumb alt=Page 2: crizotlnlb-atentionari · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut cursul pri src=https:reader040fdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 3button div class=trans-image a href=https:reader040fdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5page3jpg target=_blank amp-img class=trans-thumb alt=Page 3: crizotlnlb-atentionari · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut cursul pri src=https:reader040fdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 4button div class=trans-image a href=https:reader040fdocumentecomreader040viewer20220412085d66e41c88c99356368b901ahtml5page4jpg target=_blank amp-img class=trans-thumb alt=Page 4: crizotlnlb-atentionari · cu crizotinib peste 14700 de pacienti insuficienta cardiac la 40 frecventå de raportare: 027% mgjoritatea caurilor aceasta a apArut cursul pri...